How does Latvia rank globally on Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)?

In 2021, Latvia ranked #115 out of 185 countries reporting Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%).

Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)

Name: Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Creator: World Bank
License: https://datacatalog.worldbank.org/public-licenses#cc-by

In 2021, Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) was 13.30.

That's up 3.1% from 2020, the highest value since 2018.

The global average for this indicator in 2021 was 16.42 . Latvia ranks #115 globally out of 185 reporting countries. Within Europe & Central Asia, it ranks #15 of 48.

Source: World Bank Open Data (SH.DYN.NCOM.FE.ZS) • Data as of 2021

Trend (2002–2021)

2020 · COVID-19 pandemic
2004 · EU enlargement (10 new members)

Highlights

Peak: 18.50; 2003
Trough: 12.90; 2020
1-year change: +3.1%
5-year change: -2.2%; -0.4% / yr
10-year change: -16.9%; -1.8% / yr

Historical Data — Last 10 Years

Year	Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
2021	13.3000
2020	12.9000
2019	13.0000
2018	14.1000
2017	13.8000
2016	13.6000
2015	13.9000
2014	14.3000
2013	14.5000
2012	15.0000

About Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

Indicator code: SH.DYN.NCOM.FE.ZS • Category: Health & Population

Frequently asked questions

What was Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in 2021?: In 2021, Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) was 13.30, according to World Bank Open Data.
Is Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) rising or falling?: Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) rose 3.1% from 2020 to 2021.
How does Latvia rank globally on Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)?: In 2021, Latvia ranked #115 out of 185 countries reporting Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%).
How does Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) compare to the world average?: The global average for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in 2021 was 16.42, so Latvia is below the world average. Within Europe & Central Asia, it ranks #15 of 48.
What is Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) and how is it measured?: Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

Download this data: CSV JSON

Source: World Bank Open Data (SH.DYN.NCOM.FE.ZS), CC BY 4.0.